Views

CrossRef citations to date

Altmetric

Original Article: Clinical

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

Mary GleesonThe Royal Marsden Hospital, London and Surrey, UK; View further author information

Clare PeckittThe Royal Marsden Hospital, London and Surrey, UK; View further author information

David CunninghamThe Royal Marsden Hospital, London and Surrey, UK; Correspondence[email protected]
View further author information

Adam GibbThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Eliza A. HawkesDepartment of Oncology and Clinical Haematology, Austin Health, Heidelberg, Australia; ;Eastern Health, Melbourne, AustraliaView further author information

Morgan BackThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Binnaz YasarThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Kate FoleyThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Rebecca LeeThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Joanna DashThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Hannah JohnsonThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Catherine O’HaraThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Andrew WotherspoonThe Royal Marsden Hospital, London and Surrey, UK; View further author information

Ayoma AttygalleThe Royal Marsden Hospital, London and Surrey, UK; View further author information

Lia MenasceThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Patrick ShenjereThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Mike PotterThe Royal Marsden Hospital, London and Surrey, UK; View further author information

Mark E. EthellThe Royal Marsden Hospital, London and Surrey, UK; View further author information

Claire DeardenThe Royal Marsden Hospital, London and Surrey, UK; View further author information

John RadfordThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

Ian ChauThe Royal Marsden Hospital, London and Surrey, UK; View further author information

Kim LintonThe University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; View further author information

show all

Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (24.4 MB)

Supplementary Table 4.Overall survival by IPTCLP for all patients

Download MS Word (15.2 KB)

Supplementary Table 3: Univariate analysis of overall survival for CHOP treated patients (n=103)

Download MS Word (19.5 KB)

Supplementary Table 2: Univariate analysis of overall survival (n=156)

Download MS Word (19.7 KB)

Supplementary Table 1: Baseline characteristics for CHOP-treated patients (n=103)

Download MS Word (15.5 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Supplementary Table 4.Overall survival by IPTCLP for all patients

Supplementary Table 3: Univariate analysis of overall survival for CHOP treated patients (n=103)

Supplementary Table 2: Univariate analysis of overall survival (n=156)

Supplementary Table 1: Baseline characteristics for CHOP-treated patients (n=103)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Supplementary Table 4.Overall survival by IPTCLP for all patients

Supplementary Table 3: Univariate analysis of overall survival for CHOP treated patients (n=103)

Supplementary Table 2: Univariate analysis of overall survival (n=156)

Supplementary Table 1: Baseline characteristics for CHOP-treated patients (n=103)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date